Protozoan diseases continue to be a worldwide social and economic health problem.
Increased drug resistance, emerging cross resistance, and lack of new drugs with novel …

Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria
therapy in endemic countries worldwide. This systematic review aims at presenting the …

Malaria control demands the development of a wide range of complementary strategies. We
describe the properties of a naturally occurring, non–genetically modified symbiotic …

For more than one hundred years, several treatments against malaria have been proposed
but they have systematically failed, mainly due to the occurrence of drug resistance in part …

Malaria is a devastating disease caused by Plasmodium parasites, resulting in
approximately 435000 deaths in 2018. The impact of malaria is compounded by the …

Background Recent studies indicate that the prevalence of non-falciparum malaria,
including Plasmodium malariae and Plasmodium ovale spp., is increasing, with some …

The intensification of malaria control interventions has resulted in its global decline, but it
remains a significant public health burden especially in sub-Saharan Africa (sSA) …

Malaria is one of the prevalent tropical diseases caused by the parasitic protozoan of the
genus Plasmodium spp. With an estimated 228 million cases, it is a major public health …

Malaria remains a major vector borne disease claiming millions of lives worldwide due to
infections caused by Plasmodium sp. Discovery and development of antimalarial drugs have …

Plasmodium falciparum Apicomplexan Apetala 2 Invasion (Pf AP2-I) transcription factor (TF)
is a protein that regulates the expression of a subset of gene families involved in P …